Lynwood Capital Management’s Immix Biopharma IMMX Stock Holding History

Lynwood Capital Management’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.24M	Buy	+405,000	New	+$1.57M	7.37%	5
2023 Q3	–	Sell	-200,250	Closed	-$539K	–	94
2023 Q2	$539K	Buy	+200,250	New	+$419K	0.68%	49
2023 Q1	–	Sell	-25,000	Closed	-$58K	–	133
2022 Q4	$58K	Buy	+25,000	New	+$33.3K	0.07%	89
2022 Q1	–	Sell	-565,297	Closed	-$2.01M	–	143
2021 Q4	$2.01M	Buy	+565,297	New	+$1.93M	1.93%	12

Other funds holding IMMX

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return

Lynwood Capital Management's IMMX Position: Q1 2024 in Review

Lynwood Capital Management opened a new position in Immix Biopharma (IMMX) in Q1 2024: 405,000 shares worth $1.24M. The stake represents 7.37% of the portfolio and ranks #5 among its holdings. This is a return to the name: Lynwood Capital Management previously reported a position in IMMX as recently as Q2 2023.

Lynwood Capital Management first reported a position in IMMX in Q4 2021 and has held it in 4 quarters since. The position peaked at $2.01M in Q4 2021. 35 funds tracked by Wall St. Rank hold IMMX as of Q1 2024.

Lynwood Capital Management held 405,000 shares of Immix Biopharma worth $1.24M as of Q1 2024.
Immix Biopharma was a new Lynwood Capital Management position in Q1 2024.
Immix Biopharma made up 7.37% of Lynwood Capital Management's portfolio in Q1 2024, its #5 holding.
Lynwood Capital Management first reported a position in Immix Biopharma in Q4 2021 and has held it in 4 quarters since.
Lynwood Capital Management's Immix Biopharma position peaked at $2.01M in Q4 2021.
35 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2024.

Based on Lynwood Capital Management's 13F filing for Q1 2024, filed 10 May 2024.